Skip to main content
Equibles
EQ logo

EQ · Equillium, Inc. · Metrics

Track EQ — free

Use EQ with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EQ.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.11 -0.31 (-12.81%) At close · Sep 11
Rebalance outlook locked
Market Cap
$133.79M
Shares
63.41M

EQ metrics

58 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.11
Market cap
$133.79M

Price action

20 metrics
Price change (1W)
-4.5%
Price change (30D)
-10.6%
Price change (3M)
-24.9%
Price change (6M)
-14.6%
Price change (YTD)
+36.1%
Price change (1Y)
+6.0%
Trailing year
Price change (5Y)
-63.9%
52-week high
$3.20
52-week low
$0.84
Change from 52-week high
-34.1%
Change from 52-week low
+151.2%
Annualized volatility
106.2%
Annualized volatility (3M)
80.7%
Beta
1.2
RSI (14D)
42.4
Price vs SMA 50
-13.1%
Price vs SMA 200
+4.7%
Avg volume (3M)
633,781
Relative volume
0.9
Average dollar volume
$1.69M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
63.41M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.3×
reciprocal yield 30.7%
P / book
2.4
reciprocal yield 41.9%
FCF yield
-15.0%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-13.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-05-27

Profitability

9 metrics
Gross margin
—
Operating margin
-20.1%
Trailing 12 months
Net margin
-19.6%
Gross profit (TTM)
—
Operating profit (TTM)
−$19.30M
Net income (TTM)
−$18.01M
Trailing 12 months
Diluted EPS (TTM)
$-0.09
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.47

Growth

11 metrics
Revenue growth YoY
-52.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$41.09M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+213.0%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-32.1%
Return on assets
-30.7%
Debt / equity
—
Current ratio
23.4
EBITDA (TTM)
−$9.15M
Free cash flow (TTM)
−$20.09M
Quick ratio
23.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$57.16M
Total assets
$58.67M
Total debt
$7.55M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$19.97M
Capital expenditures (TTM)
$118,000
R&D (TTM)
$8.58M
SG&A (TTM)
—
Stock compensation (TTM)
$3.16M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
60
13F filer change QoQ
+10
Institutional ownership
66.1%

Short interest

3 metrics
Short interest
8.5%
Latest settlement · 13.1 days to cover
Days to cover
13.1d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1746466 CUSIP 29446K106 13F (30d) 32 filings 32 filers Visit website Investor relations